JP2021519311A5 - - Google Patents

Info

Publication number
JP2021519311A5
JP2021519311A5 JP2020551971A JP2020551971A JP2021519311A5 JP 2021519311 A5 JP2021519311 A5 JP 2021519311A5 JP 2020551971 A JP2020551971 A JP 2020551971A JP 2020551971 A JP2020551971 A JP 2020551971A JP 2021519311 A5 JP2021519311 A5 JP 2021519311A5
Authority
JP
Japan
Prior art keywords
seq
composition according
acid sequence
amino acid
group
Prior art date
Application number
JP2020551971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519311A (ja
JPWO2019191598A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024854 external-priority patent/WO2019191598A1/en
Publication of JP2021519311A publication Critical patent/JP2021519311A/ja
Publication of JP2021519311A5 publication Critical patent/JP2021519311A5/ja
Publication of JPWO2019191598A5 publication Critical patent/JPWO2019191598A5/ja
Pending legal-status Critical Current

Links

JP2020551971A 2018-03-29 2019-03-29 抗微生物性バクテリオファージ由来ポリペプチド及びグラム陰性細菌に対するそれらの使用 Pending JP2021519311A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862650235P 2018-03-29 2018-03-29
US62/650,235 2018-03-29
PCT/US2019/024854 WO2019191598A1 (en) 2018-03-29 2019-03-29 Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria

Publications (3)

Publication Number Publication Date
JP2021519311A JP2021519311A (ja) 2021-08-10
JP2021519311A5 true JP2021519311A5 (https=) 2022-04-01
JPWO2019191598A5 JPWO2019191598A5 (https=) 2022-04-01

Family

ID=68058481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551971A Pending JP2021519311A (ja) 2018-03-29 2019-03-29 抗微生物性バクテリオファージ由来ポリペプチド及びグラム陰性細菌に対するそれらの使用

Country Status (11)

Country Link
US (1) US20210330738A1 (https=)
EP (1) EP3773669A4 (https=)
JP (1) JP2021519311A (https=)
KR (1) KR20210005027A (https=)
CN (1) CN112368010A (https=)
AU (1) AU2019245333A1 (https=)
BR (1) BR112020019010A2 (https=)
CA (1) CA3096236A1 (https=)
IL (1) IL277399A (https=)
MX (1) MX2020010071A (https=)
WO (1) WO2019191598A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019191633A2 (en) 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
KR20220029746A (ko) * 2019-07-05 2022-03-08 콘트라펙트 코포레이션 항미생물성 박테리오파지 유도된 폴리펩타이드 및 이의 그람 음성 및 항산성 세균에 대한 사용
EP4058468A4 (en) * 2019-11-14 2024-04-10 Contrafect Corporation POLYPEPTIDE CONSTRUCTIONS OF ANTIMICROBIAL PEPTIDE LYSINE (AMP), LYSINES, ISOLATED POLYNUCLEOTIDES ENCODING THEREFOR AND USES THEREOF
WO2021211303A1 (en) * 2020-04-14 2021-10-21 Contrafect Corporation Antiviral, bacteriophage-derived polypeptides and their use against viruses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2447823A1 (en) * 2001-05-23 2002-11-28 The University Of British Columbia Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
US8022271B2 (en) * 2003-05-16 2011-09-20 North Carolina State University Polyubiquitin Rubi3 promoter and 5' regulatory sequences
KR20090115852A (ko) * 2007-01-19 2009-11-09 카이 파마슈티컬즈 안정성 및 전달 효율을 증가시키기 위한 펩타이드 조성물의 변형
WO2010141135A2 (en) * 2009-03-05 2010-12-09 Trustees Of Boston University Bacteriophages expressing antimicrobial peptides and uses thereof
US20150315259A1 (en) * 2012-03-19 2015-11-05 Madeleine Phamaceuticals Pty Ltd Method of producing a recombinant peptide
EP4115897A1 (en) * 2015-09-17 2023-01-11 Contrafect Corporation Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
WO2019191633A2 (en) * 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
EP3840771A4 (en) * 2018-08-23 2023-04-19 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
KR20220029746A (ko) * 2019-07-05 2022-03-08 콘트라펙트 코포레이션 항미생물성 박테리오파지 유도된 폴리펩타이드 및 이의 그람 음성 및 항산성 세균에 대한 사용
EP4058468A4 (en) * 2019-11-14 2024-04-10 Contrafect Corporation POLYPEPTIDE CONSTRUCTIONS OF ANTIMICROBIAL PEPTIDE LYSINE (AMP), LYSINES, ISOLATED POLYNUCLEOTIDES ENCODING THEREFOR AND USES THEREOF
US20210324359A1 (en) * 2020-04-17 2021-10-21 Contrafect Corporation Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis

Similar Documents

Publication Publication Date Title
JP2021519083A5 (https=)
IL277119B1 (en) Antimicrobial lysine-peptide polypeptide templates, lysines, isolated polynucleotides encoding them and uses thereof
JP2021519311A5 (https=)
US20250064902A1 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
JP2024010053A5 (https=)
JPWO2019191633A5 (https=)
US11180744B2 (en) Acinetobacter lysins
JP2021533728A5 (https=)
CN112218659A (zh) 用于治疗葡萄球菌感染的治疗性噬菌体组合物
JP2021513865A5 (https=)
JP2021508501A (ja) Pseudomonas感染症を処置するためのバクテリオファージ組成物
JPWO2019191598A5 (https=)
JPWO2021180892A5 (https=)
RU2020131450A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий
JPWO2020206327A5 (https=)
KR101595976B1 (ko) 황색포도알균에 특이적 항균 활성을 가지는 리신 융합 단백질 및 이의 용도
RU2021137156A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных и кислотоустойчивых бактерий
RU2020118691A (ru) Идентификация лизинов и их производных, обладающих антибактериальной активностью против pseudomonas aeruginosa
JPWO2021097192A5 (https=)
Kuhn et al. Antimicrobial peptides in lung health and pulmonary diseases
US20220387563A1 (en) Novel polypeptides and antibiotics against Gram-negative bacterium comprising the same
RU2022126282A (ru) Новый рекомбинантный лизин и его применение в лечении грамотрицательных бактериальных инфекций
HK40086790A (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
US20220289867A1 (en) Recombinant antimicrobial multidomain polypeptide, methods of producing and uses thereof
WO2025172452A1 (en) Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain